Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Colorectal Neoplasms 64Head and Neck Neoplasms 63Squamous Cell Carcinoma of Head and Neck 60Carcinoma, Non-Small-Cell Lung 34Rectal Neoplasms 23Colonic Neoplasms 23Neoplasm Metastasis 19Neoplasms 18Carcinoma, Squamous Cell 17Pancreatic Neoplasms 13Lung Neoplasms 13Esophageal Neoplasms 11Tongue Neoplasms 9Stomach Neoplasms 9Recurrence 9Carcinoma 8Neoplasms, Squamous Cell 6Mouth Neoplasms 6Laryngeal Neoplasms 6Breast Neoplasms 6Adenocarcinoma Of Esophagus 6Parkinson Disease 4, Autosomal Dominant Lewy Body 5Esophageal Squamous Cell Carcinoma 5Adenocarcinoma of Lung 5Sarcoma 4Salivary Gland Neoplasms 4Oropharyngeal Neoplasms 4Laryngeal Diseases 4Precancerous Conditions 3Hypopharyngeal Neoplasms 3

Interventions

pembrolizumab 1Tomography, X-Ray Computed 1Radiotherapy 1Radionuclide Imaging 1Positron-Emission Tomography 1Ibuprofen 1Hydroxyurea 1Fluorouracil 1Electrocardiography 1Cetuximab 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Nose Neoplasms × Cetuximab × Clear all
NCT00462735 2018-03-13

Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer

Icahn School of Medicine at Mount Sinai

Phase 2 Completed
33 enrolled 15 charts
Head & Neck

Head and Neck Neoplasms, Laryngeal Neoplasms, Nose Neoplasms, Paranasal Sinus Neoplasms, Pharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡